Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection

Intranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection

Respiratory syncytial virus (RSV) is the leading cause of pediatric viral respiratory tract infections. Neither vaccine nor effective antiviral therapy is available to prevent and treat RSV infection. Palivizumab, a humanized monoclonal antibody, is the only product approved to prevent serious RSV i...

Full description

Bibliographic Details
Main Authors: Zhiwu Sun, Qian Wang, Ran Jia, Shuai Xia, Yuan Li, Qi Liu, Wei Xu, Jin Xu, Lanying Du, Lu Lu, Shibo Jiang
Format: Article
Language:English
Published: MDPI AG 2015-02-01
Series:Viruses
Subjects:
human serum albumin (HSA)
pre-exposure prophylaxis (PrEP)
respiratory syncytial virus (RSV)
entry inhibitor
antiviral
Online Access:http://www.mdpi.com/1999-4915/7/2/798

Similar Items

Similar Items